Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News GeneDx Holdings Corp WGS

Financial Services Healthcare Medical Care
GeneDx Holdings Corp. is a genomics company. The Company is focused on delivering personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery. The Company's segments are GeneDx inclusive of Legacy GeneDx and Legacy Sema4. The GeneDx segment primarily provides pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing... see more

Recent & Breaking News (NDAQ:WGS)

SHAREHOLDER NOTICE: Halper Sadeh LLP Investigates APR, RCM, BFC, ATVI, SMFR

PR Newswire March 7, 2022

SEMA4 HOLDINGS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Sema4 Holdings Corp. - SMFR

Business Wire March 2, 2022

SHAREHOLDER NOTICE: Halper Sadeh LLP Investigates APR, RCM, SKIL, SMFR

PR Newswire March 1, 2022

INVESTIGATION ALERT: Kaskela Law LLC Announces Stockholder Investigation of Sema4 Holdings Corp. (SMFR) in Connection with Recent Merger Announcement

Newsfile February 27, 2022

Sema4 to Report Fourth Quarter and Full Year 2021 Financial Results and Participate in Investor Conferences in March 2022

GlobeNewswire February 22, 2022

Sema4 and BioSymetrics Partner on Data-Driven Drug Discovery to Advance Precision Medicine

GlobeNewswire February 22, 2022

Sema4 to Participate at Two Upcoming Investor Conferences in February

GlobeNewswire February 3, 2022

Sema4 Announces Plans to Strengthen its Market Access Team to Drive Improved Commercial and Reimbursement Capabilities

GlobeNewswire February 1, 2022

SHAREHOLDER NOTICE: Halper Sadeh LLP Investigates VCRA, ATVI, FLMN, SMFR, SEAC

PR Newswire January 31, 2022

Halper Sadeh LLP Investigates CRHC, SMFR, ZGNX, BFC; Shareholders are Encouraged to Contact the Firm

PR Newswire January 22, 2022

SEMA4 HOLDINGS INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Sema4 Holdings Corp. - SMFR

PR Newswire January 20, 2022

Sema4 (SMFR) Stock Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Merger of Sema4 Holdings Corp. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm - SMFR

Business Wire January 18, 2022

Sema4 to Acquire GeneDx, Strengthening its Market-Leading AI-Driven Genomic and Clinical Data Platform

GlobeNewswire January 18, 2022

Sema4 Announces Preliminary Revenue for the Fourth Quarter and Fiscal Year 2021

GlobeNewswire January 10, 2022

Sema4 to Participate at the 40th Annual J.P. Morgan Healthcare Conference in January

GlobeNewswire January 3, 2022

Sema4 Reports Third Quarter 2021 Financial Results and Business Highlights

GlobeNewswire November 15, 2021

Sema4 and Mount Sinai use Machine Learning to Improve Postpartum Hemorrhage Risk Prediction

GlobeNewswire November 4, 2021

Sema4 to Participate at Three Upcoming Investor Conferences in November

GlobeNewswire November 3, 2021

Sema4 to Report Third Quarter 2021 Financial Results on Monday, November 15, 2021

GlobeNewswire October 19, 2021

Sema4 Appoints Computational Biology Expert Gustavo Stolovitzky as Chief Science Officer

GlobeNewswire September 13, 2021